Delivery Order SPE2DB22D3401-SPE2DB25FT3EV
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Contrave ER 8-90 mg tablets. The contract has a firm fixed price of $4,154.42 and a period of performance through April 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the drug Contrave ER 8-90 mg tablets. The delivery order, valued at $5,367.46, is a firm-fixed-price contract with an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,189.76 delivery order contract is for the supply of the prescription medication Contrave ER 8-90 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $12,759.44 and a completion date of May 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $11,974.28 with a completion date of June 18, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the supply of the drug Contrave ER 8-90 mg tablet. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The firm-fixed-price delivery order has a ceiling value of $1,542.82 and a period of performance through March 19, 2025. The contract was not awarded under any set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,007.04, is for the delivery of the drug Contrave ER 8-90 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,463.83, is for the delivery of the drug Contrave ER 8-90 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through May 8, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ1EW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,120.21 firm fixed-price delivery order is for the medication Contrave ER 8-90 mg tablet, with a performance period through May 5, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $10,587.49 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Contrave ER 8-90 mg tablets to support military treatment programs and facilities. The order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug...